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Abstract
Background: CD4-independence has been taken as a sign of a more open envelope structure that is
more accessible to neutralizing antibodies and may confer altered cell tropism. In the present study, we
analyzed SIVsm isolates for CD4-independent use of CCR5, mode of CCR5-use and macrophage tropism.
The isolates have been collected sequentially from 13 experimentally infected cynomolgus macaques and
have previously been shown to use CCR5 together with CD4. Furthermore, viruses obtained early after
infection were neutralization sensitive, while neutralization resistance appeared already three months after
infection in monkeys with progressive immunodeficiency.
Results: Depending whether isolated early or late in infection, two phenotypes of CD4-independent use
of CCR5 could be observed. The inoculum virus (SIVsm isolate SMM-3) and reisolates obtained early in
infection often showed a pronounced CD4-independence since virus production and/or syncytia induction
could be detected directly in NP-2 cells expressing CCR5 but not CD4 (CD4-independent-HIGH).
Conversely, late isolates were often more CD4-dependent in that productive infection in NP-2/CCR5 cells
was in most cases weak and was revealed only after cocultivation of infected NP-2/CCR5 cells with
peripheral blood mononuclear cells (CD4-independent-LOW). Considering neutralization sensitivity of
these isolates, newly infected macaques often harbored virus populations with a CD4-independent-HIGH
and neutralization sensitive phenotype that changed to a CD4-independent-LOW and neutralization
resistant virus population in the course of infection. Phenotype changes occurred faster in progressor than
long-term non-progressor macaques. The phenotypes were not reflected by macrophage tropism, since
all isolates replicated efficiently in macrophages. Infection of cells expressing CCR5/CXCR4 chimeric
receptors revealed that SIVsm used the CCR5 receptor in a different mode than HIV-1.
Conclusion: Our results show that SIVsm isolates use CCR5 independently of CD4. While the degree
of CD4 independence and neutralization sensitivity vary over time, the ability to productively infect
monocyte-derived macrophages remains at a steady high level throughout infection. The mode of CCR5
use differs between SIVsm and HIV-1, SIVsm appears to be more flexible than HIV-1 in its receptor
requirement. We suggest that the mode of CCR5 coreceptor use and CD4-independence are interrelated
properties.
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Background
Human immunodeficiency virus (HIV) and the simian
counterpart, simian immunodeficiency virus (SIV) nor-
mally enter and infect cells after engagement with CD4
and a coreceptor, usually a chemokine receptor (reviewed
by [1]). Binding to CD4 induces a conformational change
to form and expose the coreceptor binding site. Further
binding to the coreceptor induces additional rearrange-
ments such that fusion between the viral envelope and the
cell membrane can take place. The two major coreceptors
used by HIV type-1 (HIV-1) are CCR5 and CXCR4 [2-4].
Viruses using the CCR5 coreceptor (R5-phenotype) pre-
dominate early in asymptomatic HIV-1 infection, while
CXCR4-using HIV-1 (X4 phenotype) can be isolated in
approximately half of the patients that progress to AIDS
[5,6]. CCR5 is also the major coreceptor for SIV [7-9]. Fur-
thermore, both HIV and SIV have been shown to use a
wide set of alternative coreceptors, including CCR1,
CCR2b, CCR3, CXCR6, CCR8, CX3CR1/V28, gpr1, gpr15,
APJ, ChemR23 and RDC1, but the in vivo role of these
coreceptors is still unknown [1].
CD4-independent use of coreceptors by HIV and SIV has
long been an intriguing question. It has been assumed
that CD4-independence is a sign of a more open envelope
structure, more accessible to neutralizing antibodies and
conferring altered cell tropism. HIV type 2 (HIV-2) and
some SIV strains have been shown to enter cells independ-
ently of CD4 [10-14]. This was followed by reports on lab-
oratory adapted HIV-1 variants that were able of CD4-
independent infections [15-18]. CD4-independent HIV-1
was found to have a stable exposure of the coreceptor
binding site [17]. However, similar conformational
changes in the envelope have not yet been shown for SIV
or HIV-2 and it may be that the HIV-1 envelope is more
dependent on conformational changes for efficient infec-
tion than HIV-2 and SIV. Primary HIV-1 isolates that can
infect cells independently of CD4 are rare and have not
been isolated until lately [19]. However, Gorry et al.
described a neurovirulent macrophage-tropic HIV-1 iso-
late that had increased affinity for CCR5 and could infect
cells at minimal levels of CD4 [20]. Likewise, CD4-inde-
pendence of SIV envelopes has been correlated to macro-
phage tropism and sensitivity to neutralization by
heterologous sera or monoclonal antibodies [21,22]. Sim-
ilar association between CD4-independent cell entry and
sensitivity to neutralization has been reported for HIV-1
and HIV-2 [23-26]. Nevertheless, a thorough study of the
relationships between macrophage tropism, neutraliza-
tion sensitivity and CD4-independence of a large number
of primary virus isolates has not yet been performed.
Our previous studies on CD4-independent use of CCR5
and gpr15 by envelopes of sequential SIVsm isolates (of
sooty mangabey origin) showed that early reisolates from
macaques infected with a CD4-independent inoculum
maintained envelopes with a broad range of CD4-inde-
pendent use of CCR5 in a fusion assay [27]. Envelopes
from late reisolates at the time when the macaques had
developed neutralizing antibodies were CD4-dependent.
Infection with a CD4-dependent virus resulted in evolu-
tion to CD4-independence in late reisolates, indicating
that CD4-dependent use of coreceptors may change in the
course of infection [27]. Similarly, in two other studies,
rapid progression of simian AIDS was accompanied by
selection for CD4-independent variants [28,29]. Rapid
disease was characterized by absent or transient humoral
and cellular immune responses, high levels of virus repli-
cation and widespread dissemination of SIV in macro-
phages and multinucleated cells [28]. These studies did
not, however, investigate macaques with a slow disease
progression. Neither was neutralization sensitivity or
macrophage tropism of the virus variants studied. This
prompted us to investigate these issues in our material
consisting of 13 cynomolgus macaques with different dis-
ease patterns. Sequential SIVsm isolates that previously
have been characterized for coreceptor use and neutraliza-
tion sensitivity were available [30,31]. All isolates, but
one, used CCR5 for cell entry, and CCR5 was also the
major coreceptor in 70 out of 105 isolates tested. Macro-
phage tropism, evaluated as relative replication capacity
(relative to replication of SIVmac251) in monocyte-
derived macrophages, coreceptor use and sensitivity to
neutralization by autologous and heterologous sera, var-
ied with severity of SIVsm infection. Long-term non-pro-
gressor (LTNP) macaques appeared to control virus in that
virus isolates, if obtained at all, showed limited ability to
use coreceptors late in infection [31]. On the other hand,
reisolates from the majority of macaques with progressive
disease maintained use of a wide variety of coreceptors
and an effective replication capacity in macrophages
throughout the 1–5 years study period. Furthermore, neu-
tralization resistant variants emerged earlier in progressor
macaques than in LTNP macaques [30]. In the present
study we further analyse these isolates, focusing on CD4-
independence, the mode of CCR5-use and macrophage
tropism. We show that CD4-independent use of CCR5
and macrophage tropism are general properties of pri-
mary SIVsm isolates obtained from animals infected with
a CD4-independent virus. CD4-independence is more
pronounced early in infection than late. Phenotypic
changes, like an increase in dependence on CD4 and neu-
tralization resistance seem to occur earlier in progressor
(P) and slow-progressor (SP) macaques than in LTNP ani-
mals while replication capacity in macrophages did not
change during pathogenesis.Retrovirology 2007, 4:50 http://www.retrovirology.com/content/4/1/50
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Results
CD4-independent infections of NP-2 cells
NP-2 cells expressing both CD4 and CCR5 were readily
infected by CCR5-using (R5) SIVsm reisolates derived
from virus isolation cultures with peripheral blood mono-
nuclear cells (PBMC) of either macaque origin (mPBMC,
11 isolates) or human origin (hPBMC, 44 isolates) (data
not shown). All isolates but one were previously shown to
use CCR5 when tested on GHOST(3)-CCR5 and
U87.CD4-CCR5 cells [31]. One isolate derived by coculti-
vation on hPBMC used CXCR4 and CXCR6 only (12-
month isolate from macaque D24) and could not infect
NP-2 cells expressing CD4 and CCR5. Clinical status of
the macaques and description of the virus isolates are sup-
plemented [see Additional file 1].
CD4-independent use of CCR5 was tested in two ways.
First, NP2/CCR5 cells were infected and culture superna-
tants tested for reverse transcriptase (RT) activity and cul-
tures observed for syncytia formation. Isolates which were
positive using one or both of these parameters were
defined as the phenotype CD4-independent-HIGH. How-
ever, it is possible that the absence of CD4 might reduce
the amount of syncytia and therefore it was important to
analyse infection by additional techniques. To explore
whether the virus production and syncytia negative NP-2/
CCR5 cultures were infected at all, we followed a second
strategy. Infected cultures were trypsinized 7 days after
infection, cells were washed once with PBS and added to
new culture plates together with PHA-P stimulated
hPBMC. Another six days later, supernatants were col-
lected and analyzed for reverse transcriptase activity. The
phenotype of isolates that were positive for CD4-inde-
pendent use of CCR5 only after coculture with PBMC was
defined as CD4-independent-LOW. Surprisingly, the SIV-
mac 32H isolate, known to use CCR5 independently of
CD4, was of CD4-independent-LOW phenotype (Figure
1). Our results showed that, indeed, a majority of viruses
were able to use CCR5 independently of CD4 to enter
cells. However, infection of cells expressing CCR5
together with CD4 was at all times more effective than
infection of cells expressing only CCR5.
Comparison of isolates obtained on monkey and human
PBMC showed that viruses isolated on mPBMC had more
often CD4-independent-HIGH phenotype than viruses
isolated on hPBMC. In fact, the majority (seven out of
eleven) of viruses isolated on mPBMC was of CD4-inde-
pendent-HIGH phenotype and induced both syncytia and
virus production in the NP-2/CCR5 cells (Table 1). The
remaining four isolates obtained on mPBMC appeared to
be CD4-independent-LOW. Isolation on hPBMC distin-
guished these phenotypes in a time-dependent manner
(Figure 1). Accordingly, early isolates (defined as 2-week
and 3 or 4-month isolates) from 11 macaques out of 13
CD4-independent use of CCR5 by isolates obtained on  hPBMC Figure 1
CD4-independent use of CCR5 by isolates obtained 
on hPBMC. NP-2/CCR5 cells were infected with virus 
stocks containing 2.7–3.5 log10 pg RT/well. The day after 
infection cultures were washed extensively and fresh 
medium was added. Infected NP-2/CCR5 cells were followed 
for syncytia induction up to seven days after infection. RT 
was analyzed in supernatants from NP-2 cells at day 1 after 
wash and before start of cocultivation. Cocultivation of NP-
2/CCR5 cells with hPBMC was started seven days after infec-
tion and virus production was measured after additional 6 
days. CD4-independent-HIGH, virus production and/or syn-
cytia induction could be detected directly in NP-2/CCR5 
cells (dark grey). CD4-independent-LOW, productive infec-
tion in NP-2/CCR5 cells revealed only after cocultivation of 
infected NP-2/CCR5 cells with hPBMC (light grey). RT was 
analyzed with undiluted supernatants and therefore values 
above 1000 pg RT/ml cannot be separated. Detection limit 
for RT was 50 pg/ml. Values are means of duplicate infec-
tions.
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and late isolates (defined as 12-month and/or later iso-
lates) from only five macaques (out of 13) were able to
induce syncytia and/or produce RT in NP-2/CCR5 cells
(CD4-independent HIGH). However, when considering
the difference between the two matched proportions
(sequential early and late isolates) the difference was not
statistically significant (p = 0.0703, two sided McNemar's
test). McNemar's test measures the number of changes
comparing matched early and late time-points and signif-
icant proportions were not reached due to the small
number of samples. Phenotypes of sequential isolates
changed in six animals from CD4-independent-HIGH to
CD4-independent-LOW, while isolates from four animals
appeared CD4-independent-HIGH both early and late in
infection. Change in phenotype from CD4-independent-
LOW to CD4-independent-HIGH was only observed in
one animal and in two macaques the CD4-independent-
LOW phenotype did not seem to change throughout
infection.
Considering changes of CD4-independence in relation to
disease progression, phenotypic changes seemed to occur
slower in LTNP macaques than in P and SP macaques. As
early as two-weeks after infection four out of nine
macaques with progressive disease harbored viruses that
had changed to CD4-independent-LOW. In contrast, virus
isolated from the four LTNP macaques was of the CD4-
independent-HIGH phenotype, the same phenotype as
that of the inoculum virus. At three or four months after
infection CD4-independent-HIGH viruses were still iso-
lated in two out of four LTNP animals, while only three
out of nine macaques from the P and SP group harbored
viruses with the CD4-independent-HIGH phenotype.
CD4-independence of the P and SP group was fluctuating
and at the last time point four out nine macaques were
CD4-independent-HIGH. In contrast, in LTNP macaques
virus evolution was narrowed further and the CD4-inde-
pendent-HIGH phenotype was only apparent in one out
of four macaques.
Table 1: Comparison of the capacity to infect NP-2 cells by isolates on mPBMC or hPBMC.
Origin of cells for 
virus isolation
Isolatea NP-2/CD4/CCR5 
syncytiab
NP-2/CCR5 
syncytia
NP-2/CCR5+PBMC virus 
production c RT (pg/ml)
Monkey Time PI (months)
mPBMC D24 0.5 ++++ +++ >1000
3 ++++ + 803
10 § +++ - 560
C73 5 § ++++ ++ >1000
7 § ++++ ++ 649
18 ++++ + 450
C68 0.5 # ++ - 526
30 # ++ - 674
53 # ++ - 78
B173 0.5 ++++ +++ 998
39 ++++ + 827
hPBMC D24 0.5 +++ - >1000
3+ + -7 1 3
12 § - - <50
C73 0.5 § ++ - 573
3§ + + - 1 6 1
18 ++++ - >1000
C68 0.5 ++++ - <50
3 § ++++ - >1000
30 ++++ - 741
53 ++++ - 762
B173 0.5 ++++ +/- >1000
90 § ++ - >1000
39 + - 85
a Cells were infected with virus stocks containing 2.7–3.5 log10 pg RT/well except for indicated (#) isolates that were infected with 1.9–2.3 log10 pg 
RT/well. §Isolates that could not be obtained on corresponding time-points when isolating viruses on mPBMC and hPBMC, respectively. PI, time for 
virus isolation post infection.
b Induction of syncytia was observed in light microscope 5 and 7 days after infection. -, no syncytia; +, 10–20 syncytia per well; ++, syncytia covering 
20–50% of the wells; +++, syncytia covering 50–90% of the wells; ++++, syncytia covering >90% of the wells
c Virus production was measured six days after start of cocultures with human PBMC (hPBMC). Values are means of two independent infections in 
duplicate wells. Supernatant culture fluids were collected at day 7 and production of RT was analyzed. Supernatants were undiluted in the RT assay 
and therefore values above 1000 pg RT/ml cannot be separated. Cut-off detection level was 50 pg RT/mlRetrovirology 2007, 4:50 http://www.retrovirology.com/content/4/1/50
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Intracellular and extracellular virus maturation
HIV-1 virions can assemble and mature intracellularly
within macrophages and retain infectivity for several
weeks [32]. This prompted us to test whether viruses had
matured intracellularly in the NP-2/CCR5 cells and upon
cocultivation transferred to hPBMC in a cell-to-cell fash-
ion. To study possible intracellular virus assembly and
maturation, the infected NP-2 cells were detached with
trypsin and washed with PBS, lysed by the addition of
0.001% Triton X-100 and one cycle of freeze-thawing. Vis-
ual inspection in the light microscope and culturing
attempts showed that cell lysis was complete. The lysates
were then titrated on hPBMC. Presence of intracellular
virus was demonstrated in infections of NP-2/CCR5 cells
with 11 out of 19 isolates tested (Figure 2). It is possible
that the lysis procedure affected the infectivity of viruses
and this could account for the negative cultures. Interest-
ingly, the majority of virus isolates that established infec-
tion in hPBMC after infection with lysed cells were of the
CD4-independent-HIGH phenotype. Similar lysis experi-
ments were not performed with NP-2/CD4/CCR5 cell
lines because these infections showed stronger cytopathic
effect (large syncytia and pronounced cell death) than NP-
2/CCR5 cultures.
Mode of CCR5 use
To further dissect CCR5-use by SIV, the mode of CCR5-use
was evaluated in U87.CD4 cell lines expressing chimeric
receptors constructed of CCR5 and CXCR4 (Figure 3)
[33]. In the present experiments we used three chimeras
(FC-1, FC-2 and FC-4b), in which CCR5 had been
exchanged gradually, beginning with the N-terminal, for
corresponding parts of the CXCR4 molecule. FC-1 and
FC-2 differ in the first transmembrane portion, which is
CCR5 in FC-1 and CXCR4 in the FC-2 chimera. The
CXCR4 portion of FC-4b extends to the fourth transmem-
brane region. The U87.CD4 cell line is known to endog-
enously express other SIV coreceptors (GPR1 and CXCR6)
known to be used by SIV [34,35] and to control for possi-
ble GPR1 or CXCR6 use, the U87.CD4 parental cell line
was included in all experiments. No syncytia induction or
viral antigen production was observed in the U87.CD4
parental cells in parallel infections with the SIVsm isolates
(data not shown). Our results showed that the FC-1 recep-
tor was frequently used by SIVsm (93% of the hPBMC
reisolates) and FC-2 and FC-4b were also used by a high
number of isolates (78% and 71% of hPBMC reisolates,
respectively, Figure 3). However use of FC-2 and FC-4b
was rarely as effective as FC-1 use. Interestingly, the 12-
month isolates from macaque D24 which has an unusual
X4X6 phenotype [31] was only able to use FC-4b among
the panel of chimeric receptors used in this study. Twenty-
nine out of 45 of the hPBMC reisolates and eight out of 11
of the mPBMC reisolates could use all three chimeric
receptors. There was no relationship between the isolates
capacity to infect cells with the different chimeric recep-
tors and disease progression of the animals.
Replication in human and macaque MDM
Reisolates from all monkeys (45 isolates derived on
hPBMC) could readily infect human MDM (Figure 4). The
majority of isolates replicated efficiently and showed high
virus production in supernatants 15 days after infection
(values above 5000 pg/ml). Also the SIVsm isolate SMM-
3 that was used to infect the macaques replicated effi-
ciently (14111 pg RT/ml). A few isolates showed lower
replication efficacy (range 460 to 4185 pg RT/ml) and
these isolates also widely varied in replication in MDM
from different blood donors. A comparison between five
virus isolates obtained on monkey as well as human
PBMC showed similar replication capacities in monkey
MDM (data not shown). Performing the same experiment
on MDM of human origin showed that isolates obtained
on macaque PBMC tended to replicate to lower levels
(range 595 to 2100 pg RT/ml) relative to isolates obtained
on human PBMC (range 1770 to 23732 pg RT/ml). Nev-
ertheless, the hierarchy of replication capacities among
isolates was the same (data not shown). Due to the lim-
ited availability of macaque blood we could not perform
all experiments with cells from macaque origin.
Intracellular and extracellular virus maturation shown by  infection of hPBMC with lysates and supernatants of NP-2/ CCR5 cultures Figure 2
Intracellular and extracellular virus maturation 
shown by infection of hPBMC with lysates and super-
natants of NP-2/CCR5 cultures. Seven days after infec-
tion, NP-2 cells were trypsinized, washed with PBS and lysed 
by 0.001% Triton X-100 followed by one cycle of freeze-
thawing step. Lysates were titrated at five-fold dilution steps 
on hPBMC. Supernatant culture fluids from hPBMC infec-
tions were collected at day 7 and production of RT was ana-
lyzed with undiluted supernatants. The RT cut-off detection 
level was 50 pg/ml and values above 1000 pg/ml could not be 
separated. Dark grey bars represent mean virus production 
in NP-2/CD4/CCR5 cells and. light grey bars represent virus 
production in NP-2/CCR5 cells. White bars represent virus 
production measured by RT in PBMC infected with cell 
lysates diluted 1:5 from infected NP-2/CCR5 cells. Positive 
syncytia induction (SI) are indicated with +. Means of RT pro-
duction in duplicates of infection are indicated.
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We also evaluated replication capacity in macrophages
relative to the first isolate of each macaque as an alterna-
tive to observe changes in macrophage-tropism over-time.
We found that the relative differences for macrophage-tro-
pism when comparing early and late isolates was in the
range of 1 to 4.8-fold as measured by virus production in
macrophages day 15 (with one exception (monkey C93)
the difference was 28-fold). However, changes in macro-
phage tropism could not be correlated to progression of
disease.
CD4-independent use of CCR5 and neutralization 
sensitivity of SIVsm isolates
We asked the question if CD4-independence of the SIVsm
reisolates evaluated in this study correlated with neutrali-
zation sensitivity, evaluated previously [30]. For this pur-
pose we compared CD4-independence and neutralization
sensitivity evaluated as neutralization by a high titer
serum (H55:16) from a LTNP macaque (Figure 5). Similar
changes in neutralization sensitivity were also evident
when tested by autologous sera [30]. Two parameters,
CD4-independence and neutralization sensitivity allowed
us to examine early and late isolates for phenotypic
changes. The results show that early in infection CD4-
independent-HIGH and neutralization sensitive popula-
tions were in majority, since reisolates from all four LTNP
and five out of nine SP/P macaques showed this pheno-
type. A few months later this population decreased (two
out of nine P/SP macaques and two out of four LTNP
macaques) and virus populations with CD4-independent-
LOW and neutralization sensitive phenotypes expanded.
In one P animal a CD4-independent-HIGH and neutrali-
zation resistant phenotype appeared already three months
after infection and this population became prevalent at
late stages in the P/SP group.
Replication capacity in macrophages of viruses isolated on  hPBMC from progressors (A) versus slow progressors and  LTNP (B) Figure 4
Replication capacity in macrophages of viruses iso-
lated on hPBMC from progressors (A) versus slow 
progressors and LTNP (B). Macrophages were infected 
with virus stocks containing 3.0–3.1 log10 pg RT/well (in 88% 
of the cultures) and RT production was measured in MDM 
15 days after infection. Values are means from at least two 
experiments with MDM from different donors.
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Discussion
Sequential SIVsm reisolates from 13 macaques with differ-
ent disease progression were monitored for CD4-inde-
pendent use of CCR5, mode of CCR5-use and replication
capacity in macrophages. The majority of reisolates was
capable of CD4-independent infection in NP-2/CCR5
cells and could replicate efficiently in macrophages. How-
ever, productive infection in NP-2 cells expressing CCR5
but not CD4 was in most cases revealed only after coculti-
vation of infected NP-2/CCR5 cells with hPBMC (CD4-
independent-LOW). In comparison, infection of NP-2
cells expressing both CD4 and CCR5 resulted in more effi-
cient syncytia induction and productive infection. Also
the SMM-3 inoculum was capable of CD4-independent
use of CCR5 and replicated well in macrophages. Reiso-
lates obtained early in infection (2-week isolates from
nine macaques and 3 or 4-month isolates from four
macaques) showed a more pronounced CD4-independ-
ence (CD4-independent-HIGH) since virus production
and/or syncytia induction could be detected directly in
NP-2/CCR5 cells. Late isolates, especially from LTNP
macaques, were more restricted in CD4-independent
infections. This is in line with our previous study in which
we showed that envelope clones from early SIVsm reiso-
lates maintained a broad range of CD4-independence
when the macaques were infected with a CD4-independ-
ent inoculum virus [27]. In the same study, CD4-depend-
ence increased in late reisolates from macaques that
developed neutralizing antibodies to the inoculum virus
and to the early isolates.
Based on studies of CD4-independent laboratory-adapted
variants of HIV-1, Hoffman and co-workers suggested that
envelopes capable of binding to coreceptors in a CD4-
independent manner are likely to have a "more open"
conformation, similar to CD4-triggered CD4-dependent
envelopes [17]. For SIV Chen et al. showed that the crystal
structure of unligated envelope from CD4-independent
SIVmac 32H needed to refold and move parts of the enve-
lope 40 Å in order to reveal the structure of the coreceptor
binding site known from the CD4-ligated HIV-1 HXBc2
envelope previously crystallized by Kwong et al. [36,37].
Many studies have shown an association between CD4-
independence and neutralization sensitivity for HIV as
well as SIV [21-26]. However, in these studies correlation
between CD4-independence and neutralization sensitiv-
ity was based on fusion assays of pseudoviruses with
expression of various cloned envelopes. In the present
study, we used primary isolates that consist of a swarm of
viruses expressing different envelopes and closer reflect
the in vivo situation than cloned envelopes. We have pre-
viously shown with the material included in the present
study that the 2-week isolates were neutralization sensi-
tive while the 3 or 4-month isolates and especially late iso-
lates evolved to neutralization resistance [30]. Likewise,
CD4-independence and neutralization sensitivity Figure 5
CD4-independence and neutralization sensitivity. 
Phenotypic changes in CD4-independence and sensitivity of 
neutralization over-time in 13 macaques. Neutralization sen-
sitivity of three isolates (A, 2-week isolates, B, 3 or 4-month 
isolates and C, late isolates) from each macaque was tested 
with 1:20 dilution of serum [30]. Neutralization was also per-
formed with autologous serum which gave similar results 
(data not shown). Neutralization sensitivity was measured 
using the GHOST(3) cell plaque reduction assay which has a 
cut-off for neutralization at 30% (marked with a line), that is 
results below 30% are negative [67]. The majority of newly 
infected macaques harbored virus populations with a CD4-
independent-HIGH (dark grey bars) and neutralization sensi-
tive phenotype. This phenotype gradually changed to become 
a CD4-independent-LOW (light grey bars) and neutralization 
resistant (below 30%) virus population. CD4-dependent iso-
lates (white bars) were seen in both neutralization sensitive 
and neutralization resistant populations. Values are mean 
neutralization (+/- SD) of two independent assays performed 
in triplicates.
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CD4-independent use of CCR5 is more pronounced with
virus isolates obtained shortly after infection of the
macaques. Thus, newly infected macaques often harbored
virus populations with a CD4-independent-HIGH and
neutralization sensitive phenotype (Figure 5). At two
weeks after infection the CD4-independent-HIGH pheno-
type was observed in isolates from approximately half of
the P and SP macaques, while at the same time-point this
was the only phenotype present in LTNP macaques. Grad-
ual change to a CD4-independent-LOW and neutraliza-
tion resistant virus population was evident and faster in
progressors than LTNP macaques. This can be interpreted
as a sign of a more open envelope conformation early as
compared to late virus populations. Interestingly, in the
P/SP group of macaques there was also a fraction of ani-
mals that late in infection had a CD4-independent-HIGH
and neutralization resistant phenotype. Selection of CD4-
independent variants has also previously been shown to
occur in macaques with rapid progression of simian AIDS
[28,29] and was characterized by absent or transient
humoral and cellular immune responses [28]. Thus, it
appears that CD4-independent use of CCR5 evolves in
different directions in progressors and LTNP macaques. It
is tempting to speculate that in LTNP macaques the over-
all immunity is more potently controlling the virus. Loss
of immune control in progressors may lead to variants
with a more CD4-independent and open conformation of
the envelope.
CD4-independence of SIV envelopes have previously
been correlated not only to neutralization sensitivity but
to macrophage tropism as well [21,22]. Moreover, since
macrophages have a lower CD4-expression than T lym-
phocytes it has been suggested that this would influence
their susceptibility to HIV or SIV infection [38-41]. In the
present study we found a clear correlation between CD4-
independent use of CCR5 and macrophage tropism, inas-
much all isolates productively infected macrophages and
also infected cells expressing CCR5 but not CD4 as shown
by cocultivation of infected NP-2/CCR5 cells with
hPBMC, infection of hPBMC with lysates and superna-
tants from infected NP-2/CCR5 cells. Thus, the majority
of the SIVsm isolates were both macrophage-tropic and
CD4-independent. However, the correlation between
CD4-independence and macrophage-tropism was not
strict since some of the isolates that appeared negative for
CD4-independence even after cocultivation of NP-2/
CCR5 and hPBMC could replicate to high levels in macro-
phages.
In infected MDM, virus particles can be observed within
intra-cytoplasmic vesicles with characteristic multivesicu-
lar bodies known as late endosomes or major histocom-
pability complex class II compartments [42,43]. Similarly
and recently, reports have shown that large amounts of
infectious virions accumulate in endosomal compart-
ments within 293 T cells, in chronically infected human T
lymphocytes [44]and as well as in primary macrophages
[32]. Viruses accumulated intracellularly in macrophages
can retain infectivity for at least 6 weeks shown by infec-
tion of MAGI cells with cell lysates from infected macro-
phages [32]. In the present study we found that in SIVsm-
infected NP-2/CCR5 cells virus can mature intracellularly
as shown by infection of hPBMC with cell lysates from
infected cells. Virus production was also detected after
contact of NP-2/CCR5 cells with hPBMC. It is tempting to
speculate that the low or non-productive infection of non-
CD4-expressing cells may be amplified by contact with T-
lymphocytes in vivo. The importance of direct cell-to-cell
spread in HIV infections is well known [45-47]. However,
we also have to consider the possibility that the NP-2/
CCR5 cell line is not infected and that viruses are only
taken up by the NP-2/CCR5 cells in a fashion similar to
that of DC-SIGN and transferred to PBMC after cocultiva-
tion [48,49]. Dentritic cells (DC) have been shown to cap-
ture and internalize extracellular HIV or SIV via DC-SIGN
or DC-SIGNR and, without being infected, transmit virus
to T cells in trans. In our system, we could show that infec-
tion of NP-2/CCR5 cells expressing CCR5 with CD4-inde-
pendent-HIGH isolates resulted in a low level virus
production seven days after infection and we could also
observe syncytia induction in these cells. Interestingly, the
compartment where HIV is captured by DC after DC-
SIGN uptake has been shown to be similar to the multive-
sicular bodies where intracellular assembly and budding
occurs in macrophages [50,51]. Transmission of HIV
between cells has been shown to occur in an infectious or
virological synapse that locally concentrates virus and
receptors between infected and uninfected cells [52-55].
Ganesh et al. showed that viruses transferred by this syn-
apse are poorly accessible to neutralizing antibodies [53].
Accordingly, when viruses assemble, bud and mature in
endosomal compartments, this may provide means for
cell to cell transfer of virus without encountering the
immune system.
Mode of CCR5 receptor use may affect the virus-receptor
interaction at entry. A high number of our SIVsm isolates
could use all three chimeric CCR5-CXCR4 receptors
included in this study. FC-1, with only the extracellular N-
terminal exchanged for CXCR4 was the most commonly
used chimera. This is in contrast with the results of
Edinger et al. who showed that the N-terminal of CCR5 is
the critical domain for CD4-independent entry of SIVsm
envelope clones [56]. This group also found that the N-
terminal of CCR5 in chimeric CCR2b/CCR5 chemokine
receptors was sufficient for entry into CD4+ cells of the M-
tropic strain SIVmac316 and, by contrast, the strains
SIVmac239 and SIVmac251 required the presence of the
second extracellular loop of CCR5 and exhibited aRetrovirology 2007, 4:50 http://www.retrovirology.com/content/4/1/50
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decreased dependence on the amino-terminal domain
[8]. All the chimeric receptors tested in our present study
expressed the extracellular loop 2 from CCR5, but in our
hands, the N-terminal of CCR5 was usually not needed
for infection. The SIVsm isolates, as well as SIVmac 251
and SIVmac 32H used the FC-1 receptor, with a CXCR4 N-
terminal and CCR5 as second extracellular loop. This con-
trasts the use of chimeric coreceptors by primary HIV-1
R5-isolates that use FC-2 more often than FC-1. In fact FC-
1 appeared to be the most restrictively used chimeric
receptor by HIV-1 isolates [57,58]. In HIV-1 infection FC-
4b using viruses emerge in patients who later switch viral
phenotype from R5 to X4. In SIVsm infection, a surpris-
ingly high number of the SIVsm reisolates infected cells
expressing FC-4b. However, CXCR4-using SIVsm isolates
were not more common among the isolates capable of
using FC-4b compared to the total number of isolates.
Our results indicate that SIVsm uses CCR5 in a different
mode than HIV-1. HIV-1 isolates seem to be more
restricted than SIV in the interaction with different chi-
meric coreceptors. The differences between HIV-1 and SIV
are even more pronounced when viruses isolated on
mPBMC are tested, since eight out of 11 mPBMC isolates
could use all three chimeric coreceptors. It is possible that
the SIV envelope is less dependent on conformational
changes than the HIV-1 envelope and therefore less
dependent on the exact structure of the coreceptor. It is
also possible that the ability to use different variants of the
CCR5 receptor can predispose the virus for CD4-inde-
pendent entry. Again, viruses isolated on mPBMC were
more CD4-independent than viruses isolated on hPBMC,
indicating that human cells may select for CD4-depend-
ence.
Conclusion
Taken together, in this study we could show that CD4-
independent infection of CCR5 expressing cells was a
common characteristic of primary SIVsm isolates. Differ-
ent phenotypes were observed among the virus isolates
and in many cases CD4-independent infection was at a
very low level and was only rescued after cocultivation of
infected NP-2/CCR5 cells with hPBMC, defined as CD4-
independent-LOW phenotype. Isolates obtained early in
infection were often of CD4-independent-HIGH-pheno-
type. Changes towards a more CD4-dependet phenotype
occurred over time; faster in macaques with a more pro-
gressive disease than in long-term non-progressors. While
these changes were parallel with changes in sensitivity to
neutralization (Figure 5) the ability to productively infect
monocyte derived macrophages remained at steady high
levels.
CD4-independent infections may conceivably have
important consequences. First, cell and tissue tropism of
SIVsm may broaden and lead to establishment of latently
infected cell reservoirs in SIV infections. Second, intracel-
lular maturation may provide the virus with a hideaway
from the immune system, including the possibility of
direct transfer of viruses between cells. One scenario has
been reproduced by our experiments: the low or non-pro-
ductive infection of CD4 negative cells was amplified by
contact with PBMC. Our results also suggest that the SIV
envelope is less dependent, than HIV-1, on the exact struc-
ture of the coreceptor compared to HIV-1 and that the
ability to use different variants of the CCR5 coreceptor
may influence CD4-independent entry. This difference
may indicate that a higher dependence on CD4 for cell
entry as well as a more specific binding to the coreceptor
could have evolved in humans infected with HIV-1 and
led to the more the pathogenic HIV-1 virus (first suggested
by Edinger et al. in 1999 [59]).
Methods
Animals and disease progression
Female cynomolgus macaques (Macaca fascicularis) of
Chinese origin were housed at the Swedish Institute for
Infectious Disease Control. Housing and care procedures
were in compliance with the general guidelines of the
Swedish Animal Welfare Agency and all procedures were
approved by the Local Ethical Committee on Animal
Experiments. The SIVsm isolate SMM-3 (kindly provided
by P. Fultz and H. McClure, Yerkes Regional Primate
Research Center, Atlanta, GA, [60]) originated from a nat-
urally infected sooty mangabey (Cercocebus atys) was used
to infect thirteen macaques intravenously (IV) or intrarec-
tally (IR) with 10 MID50 of cell free virus stocks produced
in cultures of peripheral blood mononuclear cells
(PBMC) from cynomolgus macaques [61]. The macaques
were monitored for general clinical status. Blood samples
for virus isolation, viral load and CD4+ T-cell count deter-
minations were collected at regular intervals. The animals
were kept until development of AIDS, or if asymptomatic,
until the end of the study period, when they were eutha-
nized. SIV RNA levels in plasma were measured using a
highly sensitive quantitative competitive (QC) RT-PCR
assay with a lower detection limit of 100 RNA equiva-
lents/ml plasma, as described in details elsewhere [62].
The animals were monitored for changes in their CD4+
cell counts using two-color flow cytometric analysis as
reported previously [63].
Based on the rate of disease progression, CD4 decline,
time of death and, whenever available, viral load, the
macaques were divided into three groups: progressor (P),
slow progressor (SP) and long-term non-progressor
(LTNP) [31]. Clinical status of the macaques are supple-
mented [see Additional file 1]. There was no difference in
either the CD4 decline or viral load when comparing
macaques inoculated by different routes of infection. As
expected, decline of CD4+ T-cells was more pronouncedRetrovirology 2007, 4:50 http://www.retrovirology.com/content/4/1/50
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in the first three months of infection, while decline was
less thereafter. For the majority of animals the pattern of
viral load was consistent with the observations by Ten
Haaft et al. in that a threshold plasma virus load which
was greater than 105 RNA equivalents/ml of plasma 6 to
12 weeks after inoculation could predict a faster disease
progression [62]. In most of the P macaques plasma viral
load was high initially (>106 RNA copies/ml) and stayed
high [31]. The P macaques showed the fastest decline in
CD4+ T-cell count and all animals developed simian AIDS
or AIDS-related symptoms. Mean CD4 decline in the P
group (seven animals) was -4.27% CD4+ T-cells/month
(range -8.05 to -0.69% CD4+ T-cells/month). All P
macaques were euthanized within 27 months post-infec-
tion and the mean time to AIDS in this group was 17
months. Virus isolation frequency was high (≥ 83%) with
one exception (macaque C39: 58%). Macaques in the
slow progressor (SP) group (two animals) did not show
disease symptoms during the study period, however, the
macaques showed a higher rate of CD4 cell decline and
had a higher virus isolation frequency (-1.0% decline of
CD4+ T- cells/month and virus isolation frequency ≥
91%) than the macaques in the LTNP group (four ani-
mals, mean CD4+ T- cell decline/month -0.3% cells and
mean virus isolation frequency 51%, range 10–72%).
None of the four LTNP macaques evaluated in this study
showed any signs of disease.
Virus isolates
In the present study two to four isolates from each
macaque were used depending on virus isolation fre-
quency and the length of the macaque's survival time [see
Additional file 1]. The virus isolates have previously been
tested for coreceptor usage and neutralization sensitivity
[30,31]. The first isolate was usually obtained as early as
two weeks post infection, the second isolate by three or
four months, the third isolate was chosen at a time in
between the second and the last isolate and the last
(fourth) isolate was collected by the time of euthaniza-
tion. Virus isolation was performed by cocultivation of
cynomolgus macaque PBMC (mPBMC) with mPBMC or
with human PBMC (hPBMC) stimulated with phytophae-
magglutinin (PHA-P) [64]. Due to the restricted availabil-
ity of blood from macaques, limited numbers of isolates
were available from cocultivation with mPBMC, thus the
need for us to work with isolates obtained on hPBMC.
Reisolates were passaged no more than two times. Cell-
free supernatants were screened for the amount of reverse
transcriptase (RT) with Cavidi HS-kit Lenti RT (Cavidi
Tech, Sweden), and stored frozen at -80°C until used. SIV-
mac 32H and SIVmac 251 were used as reference virus
[14].
Infection of NP-2 and U87.CD4 cell lines
NP-2, a human glioma cell line, was engineered to stably
express human CD4 and/or human CCR5, as described
elsewhere [13,35,65]. Human glioma U87.CD4 cells, sta-
bly expressing CD4 and the chemokine receptors CCR5,
or chimeric receptors between CCR5 and CXCR4 were
previously described [2,33]. Chimeric receptors were con-
structed by replacing successively increasing portions of
CCR5 with corresponding regions of CXCR4 by a modifi-
cation of the single-overlap and extension PCR approach.
The resulting three chimeric constructs and wild-type
receptors were stably expressed in U87.CD4 cells. Parental
U87.CD4 cells, engineered to express CD4 but no chem-
okine receptor, were also included in the experiments.
Cells in 500 µl of medium per well (without selective anti-
biotics) were seeded into 48-well plates 1 or 2 days prior
to infection to obtain a 50%-confluent cell layer by the
time of infection. For infection, medium was first
removed, after which virus was added to duplicate wells in
a volume of 350 µl/well. Cells were infected with virus
stocks containing 2.7–3.5 log10 pg RT/well (median 3.2
log10 pg RT/well). After an overnight incubation, cells
were washed with 1 ml PBS (0.12 M NaCl, 0.03 M phos-
phate [pH 7.2]), 1 ml of medium with polybrene (2 µg/
ml) was added to each well, and the plates were further
incubated. The cultures were kept for 7 days, and inspec-
tion for syncytia formation was performed daily. Superna-
tant culture fluids were collected at day 1 and 7 and
production of RT was analyzed with Cavidi HS-kit Lenti
RT (Cavidi Tech, Sweden). Supernatants were run undi-
luted and therefore values above 1000 pg RT/ml were over
range. An infection was considered positive when RT
activity at day 7 was at least twice the value of day 1, or
alternatively positive when reaching above the threshold
limit (50 pg RT/ml) when day 1 supernatant was below
threshold.
Cocultivation of NP-2/CCR5 with PBMC
PBMC from seronegative human blood donors were puri-
fied by Ficoll density gradient separation and were acti-
vated with 2.5 µg/ml of PHA-P for four days. Seven days
after infection the NP-2/CCR5 cell cultures were washed
with PBS and treated with EDTA-trypsine (2.5 mM EDTA
and 0.125% trypsin) until detached from plastic. Hereaf-
ter all NP-2/CCR5 cells, from two parallel wells in the 48-
well plates, were transferred to centrifuge tubes and
washed once with PBS. The NP-2/CCR5 cells were further
transferred to new wells in a 12-well plate and mixed with
6 × 105 PBMC/well from two PBMC donors in 2 ml RPMI
medium. Supernatant culture fluids were collected after
additional 6 days and production of RT was quantified
with Cavidi HS-kit Lenti RT (Cavidi Tech, Sweden).Retrovirology 2007, 4:50 http://www.retrovirology.com/content/4/1/50
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In an additional experiment NP-2/CCR5 cells were
infected with virus isolates in parallel wells as described
above. The infected cells from two parallel wells were
lysed and the lysates were titrated on hPBMC in order to
detect infectious virus in the cytoplasm. For cell-lysis, we
adopted a method previously described by Sharova et al.
where infectious virus was recovered directly from cyto-
plasmic lysates of macrophages [32]. Briefly, cultures
from each well were first washed with 200 µl PBS and
added 200 µl trypsin (0.25%) to exclude possible virus
attached on the outer cell membrane and to detach the
cells from the plastic. Another washing step with PBS was
followed after which the cells were incubated with 200 µl
0.001% Triton X-100 in PBS for 5 minutes and put in -
80°C for complete freezing. Cells where then thawed and
raptured by mechanical force by extensive pipetting and
complete lysis was observed by microscope analysis after
staining of cells with tryptan blue. Infections with lysed
cell material in three five-fold dilution steps were per-
formed on 105 PBMC/well in 96-well plates and cells were
mixed from four human donors. Infected cultures were
incubated over night (37°C in 5% CO2 atmosphere) in
RPMI medium with 10% FBS, antibiotics and 2 µg/ml
polybrene at a total volume of 200 µl. Infections with NP-
2/CCR5 cell lysates were carried out. Next day, cultures
were washed with PBS and further incubated with fresh
medium. Supernatant culture fluids were collected at day
1 and 7 and production of RT was analyzed with Cavidi
HS-kit Lenti RT (Cavidi Tech, Sweden). The level of detec-
tion for RT production was 50 pg/ml.
Isolation and infection of monocyte-derived macrophages 
(MDM)
MDM were isolated from PBMC from blood donors or
cynomolgus macaques according to a previously estab-
lished protocol [66]. These experiments involved seven
different human MDM donors and every isolate was
tested on MDM from 2 to 4 blood donors in independent
experiments. After Ficoll separation, 15 × 105 cells/cm2
were seeded in 24- or 48-well plates in RPMI medium sup-
plemented with antibiotics, 20% FBS and 10% human
serum (HS), pooled from nine different normal donors.
Cells were cultured at 37°C in 5% CO2 atmosphere. Six
days after seeding, non-adherent cells were removed by
extensive rinsing with PBS. In addition, cultures were
treated with trypsin to further remove non-macrophage
cells. Adherent cells were maintained in medium without
HS. Cytochemical staining for non-specific esterase
(Sigma, Germany) at day 7 showed over 98% positive
cells.
After seven days the MDM cultures were infected with the
virus isolates. Prior to infection, cells were washed twice
with PBS and fresh medium containing 2 µg/ml poly-
brene was added to the wells. Macrophages were infected
with virus stocks containing 3.0–3.1 log10 pg RT/well (in
88% of the cultures). Sequential isolates from each mon-
key were tested simultaneously. The day after infection,
cultures were rinsed twice with PBS and fresh medium was
added. In order to compare the kinetics of virus replica-
tion in MDM 20 SIVsm virus isolates were tested on MDM
from four different human blood donors in a pilot study.
Supernatants of infected MDM were analyzed for virus
production by testing reverse transcriptase activity (Cavidi
HS-kit Lenti RT) at day 1, 3, 7, 11 and 15 after infection.
These experiments with peak replication at day 15 or
beginning of steady state replication at day 11 after infec-
tion, allowed us to choose day 15 for comparison of mac-
rophage tropism of viruses in following experiments (data
not shown).
Plaque reduction neutralization assay
The GHOST(3) cell line-based plaque assay is a single
cycle infectivity assay for HIV and SIV, where green fluo-
rescent protein (GFP) expression is a hallmark of infection
[67]. The assay was performed in 96-well microtiter plates
where infected single cells or syncytia appear as distinct
green fluorescent plaques and are counted as plaque-
forming units (PFU). The serum (H55:16) used in the
study was obtained from an infected monkey that
remained asymptomatic and had high neutralizing titers
towards SIVsm [30]. For the neutralization assay, virus
and heat inactivated sera were diluted and mixed in cul-
ture medium, to give 20 to 100 PFU/well and 1:20 serum
dilution. The virus and serum mixtures were incubated at
37°C for one hour, followed by further dilution in two 5-
fold steps, and distributed to triplicate wells. The day after
infection the virus-serum mixtures were replaced with
fresh medium. The cultures were checked for expression
of GFP using fluorescence microscopy three days after
infection and virus titers were calculated as PFU/ml: (aver-
age number of plaques in triplicate wells × virus dilution)/
volume in the well. The neutralizing property of the serum
was calculated as percentage plaque reduction of the virus
titration by the formula 1-(PFU with serum/PFU without
serum) × 100. Based on intra-assay variation, the cut-off
for neutralization was set to 30% (≥ 3 × SD), that is, values
below 30% are considered as negative for neutralization.
Statistic analysis
McNemar's test was used to analyze if the proportions of
CD4-independent phenotypes of paired early and late iso-
lates are the same.
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